Results 241 to 250 of about 1,207,383 (287)

Long‐Read Pan‐Cancer Transcriptomics Unravel Distinct Alteration Trends Between Gene and Isoform Expression in Tumorigenesis

iMetaMed, EarlyView.
Long‐read profiling of 144 tumor‐normal pairs identifies isoform‐level cancer dysregulation independent of gene changes. Our scoring system prioritizes isoform‐driven prognostic genes across cancers. ABSTRACT Tumorigenesis involves transcriptomic alterations at both gene and isoform levels.
Yuying Ding, Bo Wu, Dan Zhou, Qiang Li, Dingru Li, Mengyun Cai, Zhiyan Chen, Caimei Zhong, ChuanLe Xiao, Yuhua Deng   +9 more
wiley   +1 more source

Recurrence of Colorectal Cancer After Liver Transplant for Isolated Colorectal Liver Metastases: A Narrative Review. [PDF]

Cancers (Basel)
Agrawal R, Choi AJ.
europepmc   +1 more source

Identifying an appropriate endogenous control for real-time PCR of microRNAs in colorectal liver metastases: A comparison of 18s rRNA and small nuclear RNA RNU6B. [PDF]

Oncol Lett
Franz C, Hartmann S, Ulrich A, Polychronidis G, Kahlert C, Klupp F, Al-Saeedi M.   +6 more
europepmc   +1 more source

The Evolving Role of Living Donor Liver Transplantation in the Management of Colorectal Liver Metastases. [PDF]

Curr Oncol
Bhatti ABH, Nauman-Ul-Haq M, Atiq M, Khokhar US, Shafi A.   +4 more
europepmc   +1 more source

Impact of time to ablation on survival outcomes in patients with colorectal liver metastases: an inverse probability-weighted cohort study. [PDF]

BMC Cancer
Yue X, Kong Y, Huang X, Tang F, Cao X, Zhou X.   +5 more
europepmc   +1 more source

Sinusoidal injury and portal hypertension after hepatectomy for colorectal liver metastases: predictors, risk stratification, and clinical outcomes. [PDF]

Int J Colorectal Dis
Hernández-Yagüe X, López-Ben S, Aula-Olivar A, Carbajal-Ochoa W, Martínez-Sancho J, Albiol-Quer MT, Osca-Gelis G, Ortíz MR, Falgueras-Verdaguer L, Buxó M, Meléndez-Muñoz C, Figueras I Felip J.   +11 more
europepmc   +1 more source

Radiofrequency ablation for colorectal liver metastases: an evolving alternative or complement to resection? [PDF]

Hepatobiliary Surg Nutr
Sun Y, Jiang S, Wu R, Zhou B.
europepmc   +1 more source

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel Liver Metastases Workshop

, 2009
Glimelius B, Poston G, Van Cutsem E, SOBRERO, Alberto, Rougier P, Gruenberger T, Ychou M, Sixth International Colorectal, European Colorectal Metastases Treatment Group, Nordlinger B   +9 more
core   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Epidemiology of colorectal liver metastases

Surgical Oncology, 2007
In summary, the natural history of patients presenting with synchronous liver metastases has been well documented. However, the epidemiology and natural history of patients presenting with metachronous disease is scant. It is clear, therefore, that the accurate detection of occult liver metastases at the time of presentation underpins further ...
Donald C McMillan, Colin S McArdle
exaly   +3 more sources

Liver Transplantation for Colorectal Liver Metastases

Surgical Clinics of North America, 2023
Colorectal cancer is one of the most common malignancies worldwide. Approximately half of the patients diagnosed will develop colorectal liver metastases (CRLM). Liver resection has a 50% 5-year survival; however, only a fourth of cases are resectable. Unresectable CRLM has poor prognosis despite improved systemic and local ablative treatments.
Emily J, Schepers, Stephen J, Hartman, Jenna N, Whitrock, Ralph C, Quillin   +3 more
openaire   +2 more sources